Effects	effects	O	O	O	O
of	of	O	O	O	O
ouabain	ouabain	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
myocardial	myocardial	O	O	O	O
oxygen	oxygen	CHEMICALS	O	OTHERS	I
supply	supply	O	O	O	O
and	and	O	O	O	O
demand	demand	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
chronic	chronic	O	O	O	O
coronary	coronary	O	DISEASE	OTHERS	I
artery	artery	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
hemodynamic	hemodynamic	O	O	O	O
,	,	O	O	O	O
volumetric	volumetric	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
metabolic	metabolic	O	O	O	O
study	study	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
without	without	O	O	O	O
heart	heart	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
digitalis	digitalis	CHEMICALS	O	OTHERS	I
glycosides	glycosides	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
myocardial	myocardial	O	O	O	O
oxygen	oxygen	CHEMICALS	O	OTHERS	I
supply	supply	O	O	O	O
and	and	O	O	O	O
demand	demand	O	O	O	O
are	are	O	O	O	O
of	of	O	O	O	O
particular	particular	O	O	O	O
interest	interest	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
presence	presence	O	O	O	O
of	of	O	O	O	O
obstructive	obstructive	O	O	O	O
coronary	coronary	O	DISEASE	OTHERS	I
artery	artery	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
,	,	O	O	O	O
but	but	O	O	O	O
have	have	O	O	O	O
not	not	O	O	O	O
been	been	O	O	O	O
measured	measured	O	O	O	O
previously	previously	O	O	O	O
in	in	O	O	O	O
man	man	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
assessed	assessed	O	O	O	O
the	the	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
ouabain	ouabain	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
0.015	0.015	O	O	O	O
mg/kg	mg/kg	O	O	O	O
body	body	O	DISEASE	OTHERS	I
weight	weight	O	DISEASE	OTHERS	I
)	)	O	O	O	O
on	on	O	O	O	O
hemodynamic	hemodynamic	O	O	O	O
,	,	O	O	O	O
volumetric	volumetric	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
metabolic	metabolic	O	O	O	O
parameters	parameters	O	O	O	O
in	in	O	O	O	O
11	11	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
severe	severe	O	O	O	O
chronic	chronic	O	O	O	O
coronary	coronary	O	DISEASE	OTHERS	I
artery	artery	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
without	without	O	O	O	O
clinical	clinical	O	O	O	O
congestive	congestive	O	DISEASE	OTHERS	I
heart	heart	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Because	because	O	O	O	O
the	the	O	O	O	O
protocol	protocol	O	O	O	O
was	was	O	O	O	O
long	long	O	O	O	O
and	and	O	O	O	O
involved	involved	O	O	O	O
interventions	interventions	O	O	O	O
which	which	O	O	O	O
might	might	O	O	O	O
affect	affect	O	O	O	O
the	the	O	O	O	O
determinations	determinations	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
also	also	O	O	O	O
studied	studied	O	O	O	O
in	in	O	O	O	O
nine	nine	O	O	O	O
patients	patients	O	O	O	O
using	using	O	O	O	O
an	an	O	O	O	O
identical	identical	O	O	O	O
protocol	protocol	O	O	O	O
except	except	O	O	O	O
that	that	O	O	O	O
ouabain	ouabain	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
was	was	O	O	O	O
omitted	omitted	O	O	O	O
.	.	O	O	O	O

Left	left	O	O	O	O
ventricular	ventricular	O	O	O	O
end-diastolic	end-diastolic	O	O	O	O
pressure	pressure	O	O	O	O
and	and	O	O	O	O
left	left	O	O	O	O
ventricular	ventricular	O	O	O	O
end-diastolic	end-diastolic	O	O	O	O
volume	volume	O	O	O	O
fell	fell	O	O	O	O
in	in	O	O	O	O
each	each	O	O	O	O
patient	patient	O	O	O	O
given	given	O	O	O	O
ouabain	ouabain	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
even	even	O	O	O	O
though	though	O	O	O	O
they	they	O	O	O	O
were	were	O	O	O	O
initially	initially	O	O	O	O
elevated	elevated	O	O	O	O
in	in	O	O	O	O
only	only	O	O	O	O
two	two	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

Left	left	O	O	O	O
ventricular	ventricular	O	O	O	O
end-diastolic	end-diastolic	O	O	O	O
pressure	pressure	O	O	O	O
fell	fell	O	O	O	O
from	from	O	O	O	O
11.5+/-1.4	11.5+/-1.4	O	O	O	O
(	(	O	O	O	O
mean+/-SE	mean+/-se	O	O	O	O
)	)	O	O	O	O
to	to	O	O	O	O
5.6+/-0.9	5.6+/-0.9	O	O	O	O
mm	mm	O	O	OTHERS	I
Hg	hg	O	O	OTHERS	I
(	(	O	O	O	O
P	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
0.001	0.001	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
left	left	O	O	O	O
ventricular	ventricular	O	O	O	O
end-diastolic	end-diastolic	O	O	O	O
volume	volume	O	O	O	O
fell	fell	O	O	O	O
from	from	O	O	O	O
100+/-17	100+/-17	O	O	O	O
to	to	O	O	O	O
82+/-12	82+/-12	O	O	O	O
ml/m2	ml/m2	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
0.01	0.01	O	O	O	O
)	)	O	O	O	O
1	1	O	O	O	O
h	h	CHEMICALS	O	OTHERS	I
after	after	O	O	O	O
ouabain	ouabain	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
was	was	O	O	O	O
completed	completed	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
maximum	maximum	O	O	O	O
velocity	velocity	O	O	O	O
of	of	O	O	O	O
contractile	contractile	O	O	O	O
element	element	O	O	O	O
shortening	shortening	O	O	O	O
increased	increased	O	O	O	O
from	from	O	O	O	O
1.68+/-0.11	1.68+/-0.11	O	O	O	O
ml/s	ml/s	O	O	O	O
to	to	O	O	O	O
2.18+/-0.21	2.18+/-0.21	O	O	O	O
muscle-lengths/s	muscle-lengths/s	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
is	is	O	O	O	O
consistent	consistent	O	O	O	O
with	with	O	O	O	O
an	an	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
contractility	contractility	O	O	O	O
.	.	O	O	O	O

No	no	O	O	O	O
significant	significant	O	O	O	O
change	change	O	O	O	O
in	in	O	O	O	O
these	these	O	O	O	O
parameters	parameters	O	O	O	O
occurred	occurred	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
control	control	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

No	no	O	O	O	O
significant	significant	O	O	O	O
change	change	O	O	O	O
in	in	O	O	O	O
myocardial	myocardial	O	O	O	O
oxygen	oxygen	CHEMICALS	O	OTHERS	I
consumption	consumption	O	O	O	O
occurred	occurred	O	O	O	O
after	after	O	O	O	O
ouabain	ouabain	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
but	but	O	O	O	O
this	this	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
a	a	O	O	O	O
greater	greater	O	O	O	O
decrease	decrease	O	O	O	O
in	in	O	O	O	O
mean	mean	O	O	O	O
arterial	arterial	O	O	O	O
pressure	pressure	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
ouabain	ouabain	CHEMICALS	O	OTHERS	I
patients	patients	O	O	O	O
than	than	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
control	control	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
conclude	conclude	O	O	O	O
that	that	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
chronic	chronic	O	O	O	O
coronary	coronary	O	DISEASE	OTHERS	I
artery	artery	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
who	who	O	O	O	O
are	are	O	O	O	O
not	not	O	O	O	O
in	in	O	O	O	O
clinical	clinical	O	O	O	O
congestive	congestive	O	DISEASE	OTHERS	I
heart	heart	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
left	left	O	O	O	O
ventricular	ventricular	O	O	O	O
end-diastolic	end-diastolic	O	O	O	O
volume	volume	O	O	O	O
falls	falls	O	O	O	O
after	after	O	O	O	O
ouabain	ouabain	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
even	even	O	O	O	O
when	when	O	O	O	O
it	it	O	O	O	O
is	is	O	O	O	O
initially	initially	O	O	O	O
normal	normal	O	O	O	O
.	.	O	O	O	O

Though	though	O	O	O	O
this	this	O	O	O	O
fall	fall	O	O	O	O
would	would	O	O	O	O
be	be	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
decrease	decrease	O	O	O	O
in	in	O	O	O	O
wall	wall	O	O	O	O
tension	tension	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
,	,	O	O	O	O
therefore	therefore	O	O	O	O
,	,	O	O	O	O
of	of	O	O	O	O
myocardial	myocardial	O	O	O	O
oxygen	oxygen	CHEMICALS	O	OTHERS	I
consumption	consumption	O	O	O	O
,	,	O	O	O	O
it	it	O	O	O	O
may	may	O	O	O	O
not	not	O	O	O	O
be	be	O	O	O	O
of	of	O	O	O	O
sufficient	sufficient	O	O	O	O
magnitude	magnitude	O	O	O	O
to	to	O	O	O	O
prevent	prevent	O	O	O	O
a	a	O	O	O	O
net	net	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
myocardial	myocardial	O	O	O	O
oxygen	oxygen	CHEMICALS	O	OTHERS	I
consumption	consumption	O	O	O	O
.	.	O	O	O	O

Nevertheless	nevertheless	O	O	O	O
,	,	O	O	O	O
compensatory	compensatory	O	O	O	O
mechanisms	mechanisms	O	O	O	O
prevent	prevent	O	O	O	O
a	a	O	O	O	O
deterioration	deterioration	O	O	O	O
of	of	O	O	O	O
resting	resting	O	O	O	O
myocardial	myocardial	O	O	O	O
metabolism	metabolism	O	O	O	O
.	.	O	O	O	O

